The application period for the 2024 SMSNA Research Fellowship in Andrology, supported by Endo, is currently open through April 15, 2024.
July 1, 2024 – June 30, 2025
1 grant of up to $25,000.
This research fellowship program is to support clinical and/or basic research in men's health with a focus on Andrology, and foster development of expertise in the field of men's health. The funding is intended to supplement post-doctoral research activities and conference participation to present those activities.
An SMSNA member in good standing.
Institution is located with North America (US/Canada)
A medical doctor (MD/DO) who will have completed their residency training by the start of the award term and is within 5 years of completing their clinical training, and/or a PhD who is considered a post-doctoral fellow in training in a research lab and is within 7 years of completing their degree.
For all human research, IRB number and approval must be documented. Pre-clinical animal research should be reviewed and approved by the ACAR at funding institution.
Outline of proposed investigation
Preliminary research data
Proof of institutional support for salaries and benefits should be provided at time of application (letter from department chair, dean or designated institutional officer).
Letters of Support:
One letter of support from a faculty mentor
Two letters of support from SMSNA members
Other information submitted within application:
Bio-sketch (1000-word limit)
Career development plan (500-word limit)
Research abstract (300 word-limit)
Detailed description of the specific aims of the research (500-word limit)
Background of the problem being addressed (500-word limit)
Application Submission, Review, and Selection Process:
Complete online application via link below.
Applications are competitive and open to all relevant institutions and candidates in the geographic region of SMSNA and in the therapeutic area of men’s health. All applications will be evaluated by a peer review panel of expert physician-scientists and researchers. All funding decisions will be approved by the Board of the SMSNA Foundation.
Funding and Distribution of Funds
If awarded, funds are to be used for educational support related to research activities excluding indirect costs and cannot be applied to attendee registration, meals, any marketing or commercial support, gratuities, staff travels, or awards. Allowable expenses include research supplies, statistical consultation, and logistical support for the assessment and care of research subjects or animals. All awards must be used for the direct expenses of the program and may not be used to cover a salary for a position or activities that bill patient services. Overhead expenses are not allowable.
Awards will be paid to the sponsoring institution (medical school, hospital, university) and a W-9/W-8 BEN-E, as appropriate, must be completed before any funds are dispersed. Awards will not be paid directly to the applicant or mentor.
Funds will be payable in two installments available for distribution at the beginning of the grant term upon receipt of all required documentation and at the mid-point of the grant upon submission and approval of the mid-term report.
The SMSNA Foundation does not withhold taxes from the grant funds (i.e., federal withholding, social security, local or state taxes, etc.). It is the responsibility of the recipient to ensure that appropriate federal and local taxes are paid (if applicable).
The grant recipient shall provide a mid-term progress report (see award term for reference). The grant recipient shall also complete a final research fellowship grant summary report and an itemized summary of expenses along with the “Fellowship Post Program Reconciliation Form” within 30 days of the conclusion of the grant. Templates for these reports will be provided by the SMSNA Foundation.
For questions or information about this grant, please contact the SMSNA Executive Office at
Farzana Liakath Ali
University of Chicago
Dysfunction Endogenous enhancement of testosterone by Umbilical-cord mesenchymal stem cell-derived exosomes in an aging and poly chemotherapy-induced testicular dysfunctional mouse models